Situation normale

Sapphire Pharmaceuticals (Europe)
 SRL

8310 Brugge
Since 03/03/2016
BE0649580096
Financial Health Indicator
7
Equity
€-144.5K
+51% YoY
Gross Operating Margin
€-45.2K
+38% YoY
EBITDA
€-47.0K
+38% YoY
Gain/Loss
€-48.6K
+38% YoY

Sapphire Pharmaceuticals (Europe)’s business network visualized

Explore our interactive spiderweb to visually navigate Sapphire Pharmaceuticals (Europe)’s entire network of mandates and participations. Get insights into both current and historical connections.

Spiderweb Sapphire Pharmaceuticals (Europe)
Sapphire Pharmaceuticals (Europe)
  • Stephen DE PRÊTRE
    8310 Brugge
    Since 2016

Detailed insights into Sapphire Pharmaceuticals (Europe)’s financial history

See financial trends including, equity, operating income, profit/loss and employees of Sapphire Pharmaceuticals (Europe). Compare KPI’s against similar companies. Explore financial ratios, annual accounts and much more.

Financials 1
Financials 2
Financials 3
Financials 4
2023 2022 2021 2020 2019
Equity
-144.5K
-95.9K
-60.6K
-21.3K
80.9K
Gross Operating Margin
-45.2K
-32.7K
-34.2K
-82.7K
-65.3K
Gain/Loss
-48.6K
-35.3K
-39.4K
-102.2K
-102.4K
Employees
0.7

Find similar companies like Sapphire Pharmaceuticals (Europe)

Find more companies with similar activities to Sapphire Pharmaceuticals (Europe) from our extensive database.

Frequently asked questions about Sapphire Pharmaceuticals (Europe)

  • What is Sapphire Pharmaceuticals (Europe)’s official website?

    Sapphire Pharmaceuticals (Europe)’s official website is https://www.sapphiretech.com.

  • Where is Sapphire Pharmaceuticals (Europe) located?

    Sapphire Pharmaceuticals (Europe)’s headquarters is located in De Linde 107 , 8310 Brugge.

  • Who are the directors of Sapphire Pharmaceuticals (Europe)?

    Sapphire Pharmaceuticals (Europe)’s directors include
    • Stephen DE PRÊTRE

  • When was Sapphire Pharmaceuticals (Europe) founded?

    Sapphire Pharmaceuticals (Europe) was founded in 2016-03-03. Sapphire Pharmaceuticals (Europe) has been active for 9 years.

  • What are Sapphire Pharmaceuticals (Europe)’s NACEBEL codes?

    Sapphire Pharmaceuticals (Europe)’s NACEBEL codes are
    • 46660 Commerce de gros d'autres machines et équipements de bureau (2008)
    • 46751 Commerce de gros de produits chimiques industriels (2008)
    • 47730 Commerce de détail de produits pharmaceutiques en magasin spécialisé (2008)
    • 47740 Commerce de détail d'articles médicaux et orthopédiques en magasin spécialisé (2008)

  • What is Sapphire Pharmaceuticals (Europe)’s VAT number?

    Sapphire Pharmaceuticals (Europe)’s VAT number is BE0649580096.

  • What is Sapphire Pharmaceuticals (Europe)’s juridical form?

    Sapphire Pharmaceuticals (Europe)’s juridical type is Société à responsabilité limitée (SRL).

  • How is the financial situation of Sapphire Pharmaceuticals (Europe)?

    openthebox has estimated that Sapphire Pharmaceuticals (Europe)’s financial health score to be 7/10.